Pharmacological Effects of Polyphenol Phytochemicals on the Intestinal Inflammation via Targeting TLR4/NF-κB

Caiyun Yu1, Dong Wang2, Zaibin Yang3

  • 1College of Animal Sciences and Technology, Nanjing Agricultural University, No. 1 Weigang Street, Nanjing 210095, China.

Insights

Polyphenols can target the Toll-like receptor 4/nuclear factor kappa B (TLR4/NF-κB) pathway to reduce intestinal inflammation. This review explores over 20 polyphenols for potential inflammatory bowel disease (IBD) treatment.

Area of Science:

  • Immunology and Molecular Biology
  • Gastroenterology and Nutrition

Background:

  • The Toll-like receptor 4/nuclear factor kappa B (TLR4/NF-κB) pathway is central to innate immunity and inflammatory responses.
  • Dysregulation of this pathway is implicated in inflammatory bowel disease (IBD), a chronic gastrointestinal condition.
  • Polyphenols, plant-derived compounds, are recognized for their anti-inflammatory properties.

Purpose of the Study:

  • To review the pharmacological effects of various polyphenols on intestinal inflammation.
  • To investigate the potential of targeting the TLR4/NF-κB pathway with polyphenols for IBD treatment.

Main Methods:

  • Comprehensive literature review of studies investigating polyphenols and their impact on the TLR4/NF-κB signaling pathway.
  • Analysis of over 20 different polyphenol compounds for their efficacy in alleviating intestinal inflammation.
  • Focus on mechanisms involving the TLR4/NF-κB pathway in the context of IBD.

Main Results:

  • Polyphenols demonstrate significant potential in modulating the TLR4/NF-κB pathway.
  • Numerous polyphenols exhibit anti-inflammatory effects relevant to IBD.
  • Evidence suggests these compounds can reduce key inflammatory mediators.

Conclusions:

  • Targeting the TLR4/NF-κB pathway with polyphenol phytochemicals represents a promising therapeutic strategy for IBD.
  • Further clinical research is warranted to explore the application of these natural compounds in managing intestinal inflammation.

Related Concept Videos

Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
176
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
7.8K
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF01:24

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
227
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
403
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
534
Inflammatory Response01:28

Inflammatory Response

An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
6.6K